Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Fam Pract ; 53(11): 890-4, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15527726

ABSTRACT

Antifungal medications for intravaginal use have been available in the United States for more than a decade. Women may be inclined to self-diagnose yeast infections with any vaginal discharge or other vulvovaginal symptoms that they deem abnormal. As we saw in the first part of this article, "Abnormal vaginal discharge: Using office diagnostic testing more effectively" (J Fam Pract 2004; 53[10]:805-814), abnormal discharge is more likely to be bacterial vaginosis or no pathogen at all. Potential delay in diagnosis and treatment of a sexually transmitted disease is also a concern. Increasing resistance of Candida sp. to imidazoles is associated with indiscriminate use of over-the-counter products.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Vaginal Discharge/drug therapy , Vaginal Discharge/microbiology , Vaginal Diseases/complications , Vaginal Diseases/drug therapy , Candidiasis, Vulvovaginal/complications , Candidiasis, Vulvovaginal/drug therapy , Clindamycin/therapeutic use , Female , Humans , Metronidazole/therapeutic use , Nonprescription Drugs/therapeutic use , Recurrence , Risk Factors , Self Medication/statistics & numerical data , Sexually Transmitted Diseases/complications , Sexually Transmitted Diseases/drug therapy , Trichomonas Vaginitis/complications , Trichomonas Vaginitis/drug therapy , United States/epidemiology , Vaginal Discharge/epidemiology , Vaginal Diseases/epidemiology , Vaginal Diseases/microbiology , Vaginosis, Bacterial/complications , Vaginosis, Bacterial/drug therapy , Women's Health
SELECTION OF CITATIONS
SEARCH DETAIL
...